IR@PKUHSC  > 北京大学第一临床医学院  > 神经内科
学科主题临床医学
Lamivudine/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion
Xu, Hongliang1; Wang, Zhaoxia1; Zheng, Lemin2,3,4; Zhang, Wei1; Lv, He1; Jin, Suqin1; Yuan, Yun1
刊名JOURNAL OF CLINICAL PATHOLOGY
2014-11-01
DOI10.1136/jclinpath-2013-202069
67期:11页:999-1005
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Pathology
资助者National Natural Science Foundation of China ; Twelfth Five Years Plan ; National Natural Science Foundation of China ; Twelfth Five Years Plan
研究领域[WOS]Pathology
关键词[WOS]CHRONIC HEPATITIS-B ; CULTURED HUMAN-CELLS ; LONG-TERM ; DYNAMICS ; TOXICITY ; THERAPY ; COMPLEMENTATION ; CYTOTOXICITY ; TELBIVUDINE ; ZIDOVUDINE
英文摘要

Aims Myopathy or neuropathy has been associated with lamivudine/telbivudine therapy in hepatitis B patients. We aim to describe the pathological changes of lamivudine/telbivudine-associated neuromyopathy.

Methods We retrospectively recruited six patients who were diagnosed with nucleotide analogues-associated myopathy or neuropathy. Muscle and nerve biopsy were performed, and the specimens were prepared for the light microscopy and electron microscopy. Genomic DNA was extracted from frozen muscle specimens, and the mitochondrial DNA (mtDNA) content was quantified by real-time PCR.

Results Recovery of the myopathy can be achieved after the discontinuation or changing the drugs to entecavir. Muscle and nerve biopsy revealed similar changes under either the light or electronic microscopy in all the subjects. Quantitative real-time PCR revealed decrease of mtDNA content in the affected muscle.

Conclusions MtDNA depletion results in mitochondrial dysfunction in the lamivudine/telbivudine-associated neuromyopathy. Myopathy was characterised by mitochondrial dysfunction accompanied with neurogenic damage due to axonal neuropathy. Ultrastructure changes of mitochondria included vacuolisation, simplification of the cristae and homogenised matrix.

语种英语
所属项目编号30870864 ; 2011ZX09307-001-07
资助者National Natural Science Foundation of China ; Twelfth Five Years Plan ; National Natural Science Foundation of China ; Twelfth Five Years Plan
WOS记录号WOS:000344067700012
Citation statistics
Cited Times:11[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/62001
Collection北京大学第一临床医学院_神经内科
作者单位1.Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China
2.Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Cardiovasc Sci, Beijing 100191, Peoples R China
3.Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Syst Biomed,Sch Basic Med Sci, Beijing 100191, Peoples R China
4.Peking Univ, Hlth Sci Ctr, Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China
Recommended Citation
GB/T 7714
Xu, Hongliang,Wang, Zhaoxia,Zheng, Lemin,et al. Lamivudine/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion[J]. JOURNAL OF CLINICAL PATHOLOGY,2014,67(11):999-1005.
APA Xu, Hongliang.,Wang, Zhaoxia.,Zheng, Lemin.,Zhang, Wei.,Lv, He.,...&Yuan, Yun.(2014).Lamivudine/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion.JOURNAL OF CLINICAL PATHOLOGY,67(11),999-1005.
MLA Xu, Hongliang,et al."Lamivudine/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion".JOURNAL OF CLINICAL PATHOLOGY 67.11(2014):999-1005.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Xu, Hongliang]'s Articles
[Wang, Zhaoxia]'s Articles
[Zheng, Lemin]'s Articles
百度学术
百度学术Similar articles in
[Xu, Hongliang]'s Articles
[Wang, Zhaoxia]'s Articles
[Zheng, Lemin]'s Articles
必应学术
必应学术Similar articles in
[Xu, Hongliang]'s Articles
[Wang, Zhaoxia]'s Articles
[Zheng, Lemin]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.